H Motamedi, MM Ari, A Alvandi, R Abiri - Frontiers in Microbiology, 2024 - frontiersin.org
While significant progress has been made in understanding and applying gene silencing mechanisms and the treatment of human diseases, there have been still several obstacles in …
Y Cao, Y Hao, Z Li, S Liu, L Wang - Biomedicine & Pharmacotherapy, 2016 - Elsevier
This study was designed to investigate the inhibition activity of polysaccharide extract from Laminaria japonica against RSV. The polysaccharide from Laminaria japonica was isolated …
Emerging therapies based on localized delivery of siRNA to lungs have opened up exciting possibilities for treatment of different lung diseases. Localized delivery of siRNA to lungs has …
M Martín-Vicente, S Resino, I Martínez - Biomolecules, 2019 - mdpi.com
Human respiratory syncytial virus (HRSV) infection is a common cause of severe lower respiratory tract diseases such as bronchiolitis and pneumonia. Both virus replication and …
Aim: Human respiratory syncytial virus (HRSV) is a common cause of respiratory infections, particularly in infants and the elderly. Ribavirin is the only US FDA-approved antiviral drug …
A Salimi, T Jafarzadeh, SM Mohammadi - academia.edu
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has impressed many people in the world. Despite …
Hepatitis viruses (hepatotropic viruses) are classified into five kinds, denoted by the letters A, B, C, D, and E, each with its own unique genotypes, clinical implications, and geographic …
INTRODUCTION: Respiratory syncytial virus (RSV) is a threatening agent causing lower respiratory infections (LRI) among children, where no vaccine is available. RSV expresses …